EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54,865 | -92.9% | 46,496 | -54.5% | 0.00% | -100.0% |
| Q3 2022 | $770,000 | -52.4% | 102,204 | -60.2% | 0.00% | -50.0% |
| Q2 2022 | $1,618,000 | -42.0% | 256,813 | -23.6% | 0.00% | -33.3% |
| Q1 2022 | $2,789,000 | +1759.3% | 336,047 | +1060.1% | 0.00% | – |
| Q4 2021 | $150,000 | -47.6% | 28,967 | +24.3% | 0.00% | – |
| Q4 2020 | $286,000 | -63.6% | 23,295 | -75.8% | 0.00% | -100.0% |
| Q3 2020 | $785,000 | -62.5% | 96,403 | -55.7% | 0.00% | -50.0% |
| Q2 2020 | $2,091,000 | +307.6% | 217,813 | +188.8% | 0.00% | +100.0% |
| Q1 2020 | $513,000 | -38.0% | 75,428 | +35.8% | 0.00% | 0.0% |
| Q4 2019 | $827,000 | +458.8% | 55,537 | +284.3% | 0.00% | – |
| Q3 2019 | $148,000 | – | 14,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |